The Prospective Effect of Access to Medical Care on Health-Related Quality-of-Life Outcomes in Patients with Symptomatic HIV Disease

Medical Care

Volumn 36, Issue 3, 1998, Pages 295-306

  Cunningham, William E ^a   Hays, Ron D ^a,b   Ettl, Margo K ^a   Dixon, Wilfrid J ^a   Liu, Rebecca Ching Chi ^a   Beck, C Keith ^c   Shapiro, Martin F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Access; AIDS; Quality of life

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; METHODOLOGY; MORTALITY; PROSPECTIVE STUDY; PUBLIC HOSPITAL; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICS; TIME; TREATMENT OUTCOME; UNITED STATES; UTILIZATION REVIEW;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HOSPITALS, PUBLIC; HUMANS; INTERVIEWS; LOS ANGELES; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0032013089     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199803000-00007     Document Type: Article

References (21)

1. Cunningham WE, Hays RD, Williams KW, et al. Access to medical care and health-related quality of life for low income, symptomatic, HPV-infected individuals. Med Care 1995;33:739.
2. Wachtel T, Piette J, Mor V, et al. Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument. Ann Intern Med 1992;116:129.
3. Cockrell JR, Folstein MF. Mini-Mental State examination (MMSE). Psychoparmacol Bull 1988;24:689.
4. Siu AL. Screening for dementia and investigating its causes. Ann Intern Med 1991;115:122.
5. Mor V, Fleishman JA, Dresser M, et al. Variations in health service use among HIV-infected patients. Med Care 1992;30:17.
6. Crystal S. Healthcare barriers and utilization patterns among intravenous drug users with HIV disease. AIDS & Public Policy Journal 1992;7:187.
7. Safran DG, Tarlov AR, Rogers WH. Primary care performance in fee-for-service and prepaid health care systems: Results from the medical outcomes study. JAMA 1994;271:1579.
8. Tukey J. Exploratory data analysis. Readington, MA: Addison-Wesley Press, 1977.
9. Hays RD, Cunningham WE, Ettl MK, et al. Health-related quality of life in HIV disease. Assessment 1995;2:363.
10. Hays RD, Cunningham WE, Shapiro MF. Derivation of physical and mental health composite indices in the HIV Outcomes Study. Santa Monica, CA: RAND, 1996:P-7957.
11. Moser CI. On the reliability of a weighted composite. Psychometrika 1943;8:161.
12. Taylor JM, Cumberland WG, Sy JP. A stochastic model for analysis of longitudinal AIDS data. Journal of the American Statistical Association 1994;89:727.
13. Mausner JS, Bahn AK. Adjustment of rates. In: Epidemiology: An introductory test. Philadelphia, PA: W.B. Saunders Co., 1974:146.
14. Kazis L, Anderson J, Meenam R. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl):178.
15. Markson LE, Turner BJ, Cocroft J, Houchens R, Fanning TR. Clinic services for persons with AIDS experience in a high-prevalence state. J Gen Intern Med 1997;12(3):141.
16. Stanton DL, Wu AW, Moore RD, et al. Functional status of persons with HIV infection in an ambulatory seeing. J Acquir Immune Defic Syndr Hum Retrovirol 1994;7:1050.
17. Curtis RJ, Patrick DL. Race and survival time with AIDS: A synthesis of the literature. Am J Public Health 1993;83:1425.
18. Fleishman JA, Hsia DC, Hellinger FJ. Correlates of medical service utilization among people with HIV infection. Health Serv Res 1994;29:527.
19. Fleishman JA, Mor V. Insurance status among people with AIDS: Relationships with sociode mographic characteristics and service use. Inquiry 1993;30:180.
20. Moore RD, Stanton D, Gopalan R, et al. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994;330:763.
21. Stein MD, Piette J, Mor V, et al. Differences in access to Zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med 1991;6:35.